Scholarlink

<p>The aim of this study is to assess the associations of urinary genistein and endothelial activation and stress index (EASIX) with 10-year atherosclerotic cardiovascular disease (ASCVD) risk. This cross-sectional analysis employed data obtained from the National Health and Nutrition Examination Survey (NHANES). Weighted univariable and multivariable logistic regression models examined EASIX–ASCVD risk correlations, with odds ratio and 95% confidence interval [OR (95%CI)] as effect measures. The potential interactions were explored between EASIX and genistein on 10-year ASCVD risk using additive and multiplicative interaction analyses. The relationships of EASIX and 10-year ASCVD risk were further assessed at different genistein levels. Subgroup analyses examined age, BMI, diabetes, hypertension, and dyslipidemia categories. Totally, 4478 eligible participants were stratified into low-risk (<i>n</i> = 2157) and high-risk (<i>n</i> = 2321) ASCVD groups. Elevated levels of EASIX (OR = 1.35, 95% CI 1.18–1.54), EASIX<sub>median</sub> ≥ 0.427 (OR = 1.40, 95% CI 1.14–1.73), EASIX<sub>RCS</sub> ≥ 0.434 (OR = 1.45, 95% CI 1.18–1.77), EASIX<sub>quartile</sub> (0.325–0.427, OR = 1.48, 95% CI 1.05–2.07; 0.427–0.567, OR = 1.51, 95% CI 1.08–2.10; ≥ 0.567, OR = 2.08, 95% CI 1.57–2.77), and log2(EASIX) (OR = 1.32, 95% CI 1.19–1.46) were associated with higher odds of 10-year ASCVD. Low genistein levels presented no significant correlation with 10-year ASCVD risk. The multiplicative interaction between EASIX and genistein levels was significant. When genistein levels &lt; 54.105&#xa0;µg/g, the connections between elevated EASIX levels and higher 10-year ASCVD risk were established in subgroups of age &lt; 60&#xa0;years, BMI ≥ 25&#xa0;kg/m<sup>2</sup>, non-diabetes, hypertension, and dyslipidemia. Elevated EASIX levels correlated with a higher 10-year ASCVD risk. Whether genistein modulates this association requires further validation, which may have potential implications for ASCVD prevention strategies in the general population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Regulating effect of genistein on the association of endothelial activation and stress index with atherosclerotic cardiovascular disease risk: a cross-sectional study of the NHANES database

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月26日

查看全文
  • Yongliang Huang,
  • Huijuan Lan,
  • Hongchuan Yang

摘要

The aim of this study is to assess the associations of urinary genistein and endothelial activation and stress index (EASIX) with 10-year atherosclerotic cardiovascular disease (ASCVD) risk. This cross-sectional analysis employed data obtained from the National Health and Nutrition Examination Survey (NHANES). Weighted univariable and multivariable logistic regression models examined EASIX–ASCVD risk correlations, with odds ratio and 95% confidence interval [OR (95%CI)] as effect measures. The potential interactions were explored between EASIX and genistein on 10-year ASCVD risk using additive and multiplicative interaction analyses. The relationships of EASIX and 10-year ASCVD risk were further assessed at different genistein levels. Subgroup analyses examined age, BMI, diabetes, hypertension, and dyslipidemia categories. Totally, 4478 eligible participants were stratified into low-risk (n = 2157) and high-risk (n = 2321) ASCVD groups. Elevated levels of EASIX (OR = 1.35, 95% CI 1.18–1.54), EASIXmedian ≥ 0.427 (OR = 1.40, 95% CI 1.14–1.73), EASIXRCS ≥ 0.434 (OR = 1.45, 95% CI 1.18–1.77), EASIXquartile (0.325–0.427, OR = 1.48, 95% CI 1.05–2.07; 0.427–0.567, OR = 1.51, 95% CI 1.08–2.10; ≥ 0.567, OR = 2.08, 95% CI 1.57–2.77), and log2(EASIX) (OR = 1.32, 95% CI 1.19–1.46) were associated with higher odds of 10-year ASCVD. Low genistein levels presented no significant correlation with 10-year ASCVD risk. The multiplicative interaction between EASIX and genistein levels was significant. When genistein levels < 54.105 µg/g, the connections between elevated EASIX levels and higher 10-year ASCVD risk were established in subgroups of age < 60 years, BMI ≥ 25 kg/m2, non-diabetes, hypertension, and dyslipidemia. Elevated EASIX levels correlated with a higher 10-year ASCVD risk. Whether genistein modulates this association requires further validation, which may have potential implications for ASCVD prevention strategies in the general population.